De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Clinical trial NCT05541016 · RECRUITING

Trial details

NCT number: NCT05541016
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8

Start date: 2023-02-21
Primary completion: 2028-08-01
Enrollment: 455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.